Related Experiment Video
Updated: Jan 13, 2026
08:09
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
Published on: April 6, 2015
12.1K
Antibody-Empowered Nanomedicine for Precise Biomedical Applications
Chen Chen1, Xinglin Chen1, Zhenhao Gao1
1Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, P. R. China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|January 12, 2026
Summary
Antibody-empowered nanomedicine enhances disease targeting and treatment by overcoming limitations of conventional nanoparticles. This review explores antibody functionalization, nanomedicine classification, and applications for precision medicine.
Area of Science:
- Nanotechnology
- Immunology
- Biomedical Engineering
Background:
- Conventional nanomedicine faces challenges in clinical efficacy due to passive targeting and limited therapeutic mechanisms.
- Suboptimal accumulation at disease sites and compromised therapeutic outcomes hinder nanomedicine's full potential.
- Antibodies offer unparalleled targeting specificity and immune-activating capabilities, crucial for enhancing nanoparticle function.
Purpose of the Study:
- To systematically review the progress of antibody-empowered nanomedicine.
- To discuss antibody functionalization strategies, their pros, cons, and applications.
- To examine the classification, biomedical applications, and clinical translation challenges of antibody-nanomedicines.
Main Methods:
- Systematic review of current literature on antibody-empowered nanomedicine.
- Discussion of various antibody functionalization techniques for nanoparticles.
- Classification of nanomedicines based on antibody structures (e.g., IgG-like, fragments, fusion formats).
Main Results:
- Antibody functionalization significantly improves nanoparticle targeting and therapeutic efficacy.
- Diverse antibody structures enable tailored nanomedicine designs for specific applications.
- Antibody-nanomedicines show promise in diagnostics, bioimaging, and treating various diseases.
Conclusions:
- Antibody-empowered nanomedicine represents a significant advancement over conventional approaches.
- Further research and development are needed to overcome challenges in clinical translation.
- This field holds great potential for advancing precision medicine and improving patient outcomes.
